Polaryx Therapeutics, Inc. - Common Stock (PLYX)

2.6700
-0.2200 (-7.61%)
NASDAQ · Last Trade: Feb 19th, 4:23 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
What's Going On With Polaryx Therapeutics Stock Wednesday?benzinga.com
Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.
Via Benzinga · February 18, 2026
Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plansbenzinga.com
Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.
Via Benzinga · February 17, 2026